Free Live Webinar: Automating Medical Devices QA Process with Agentic AI Reserve your Seat Now!

HEALTHCARE REGULATORY COMPLIANCE

Regulatory complexity shouldn’t slow innovation.

Quality and regulatory gaps often emerge when evidence, engineering workflows, and compliance responsibilities are disconnected. We help turn those gaps into controlled, traceable operations.

Regulatory complexity across markets

Different markets bring different standards, submission expectations, and evidence requirements. Early alignment helps avoid costly changes later.

Validation & traceability gaps

Requirements, test evidence, and risk records can exist in separate systems without a defensible chain connecting them.

Reactive CAPA & remediation

Findings can trigger rushed root-cause analysis and repeat work when corrective actions are not tied to effectiveness evidence.

Disconnected quality & engineering

When engineering moves faster than the quality system, controls are applied retroactively, creating rework and revalidation.

AI & SaMD governance

AI-enabled and software-based medical products need lifecycle, change-management, risk, and data-governance structures that can evolve with the product

Audit & submission risks

Evidence assembled at the end is harder to defend. Readiness improves when records are structured for retrieval from the start.

Ready to modernize your quality & regulatory operations?

Why QMS matters

Quality management should strengthen the business, not just satisfy an audit.

A controlled QMS creates a repeatable operating model for quality, evidence, risk, and change—helping teams stay prepared as products, systems, and regulatory expectations evolve.

01

Standardized quality operations

Defined processes, controlled documentation, and consistent approvals create a reliable quality baseline across teams.

02

End-to-end traceability

Connect user needs, requirements, design, verification, validation, and risk controls so evidence can be retrieved when needed.

03

Risk-based compliance

Focus validation and quality effort where product and patient risk is highest rather than applying the same burden everywhere.

04

Continuous audit readiness

Maintain evidence as part of day-to-day operations instead of rebuilding the record immediately before an inspection.

05

Operational scalability

Establish quality infrastructure that can support additional products, sites, workflows, and regulatory requirements.

Integrated Quality Management Framework

Our integrated quality & regulatory framework.

Five connected pillars bring regulatory alignment, quality processes, validation, risk management, and digital infrastructure into one operating model.

01

QMS Core

Defines controlled processes, SOPs, document management, design controls, change control, and CAPA practices that govern quality.

A controlled foundation for repeatable quality operations.
02

Regulatory Alignment

Maps product classification, applicable standards, submission expectations, and inspection requirements to the product lifecycle.

A defensible regulatory pathway with clear evidence requirements.
03

Validation & Verification

Applies software verification, validation, CSA, and protocol-based testing proportionate to actual product and system risk.

Evidence that demonstrates intended performance.
04

Risk Management & Remediation

Connects hazards, risk controls, CAPA, gap assessments, and remediation activities to the engineering and quality record.

Root causes addressed with measurable effectiveness.
05

Digital Quality Infrastructure

Operationalizes quality through eQMS, workflow automation, complaint handling, surveillance, and integration with clinical and engineering systems.

Quality data that flows instead of being re-entered.

REGULATORY COMPLIANCE SERVICES

QMS & regulatory services

Integration strategies tailored to domain-specific clinical workflows.

QUALITY MANAGEMENT SYSTEM LIFECYCLE

QMS elements we support.

Seven connected elements form a continuous quality lifecycle. Each stage produces evidence and controls that support the next.

Requirements Management

User needs and intended use are captured as testable requirements, each uniquely identified so downstream evidence can reference it.

Applies to: SaMD, device software, clinical platforms
IEC 62304 §5.1

Design & Development Controls

Design inputs, outputs, reviews and transfers are governed by a controlled process with documented approval at each gate.

Applies to: Medical device, SaMD, IVD
FDA QMSR / 21 CFR Part 820, ISO 13485:2016 §7.3

Verification & Validation

Verification confirms the product was built to specification; validation confirms it meets user needs in the intended environment of use.

Applies to: Software, systems, instrumentation, interfaces
IEC 62304 §5.6-5.7

Risk Management

Hazards are identified, controls are implemented as design requirements, and residual risk is evaluated against clinical benefit.

Applies to: All regulated product development
ISO 14971

Documentation & DHF

The design history file assembles the full development record as a controlled, retrievable set rather than a retrospective compilation.

Applies to: Device, SaMD, IVD portfolios
ISO 13485 §4.2

CAPA & Change Control

Nonconformities and changes route through documented root cause analysis, impact assessment and effectiveness verification before closure.

Applies to: Operating quality systems
FDA QMSR / ISO 13485:2016

Post-Market Surveillance

Field data, complaints and performance signals are collected and fed back into risk management and design.

Applies to: Marketed products, EU and US
EU MDR Art. 83-86

COMPLIANCE EXPERTISE

Compliance expertise across regulated healthcare environments.

Our expertise spans the quality, validation, risk, audit, and interoperability controls that regulated healthcare organizations need to operate with confidence.

SaMD Compliance

IEC 62304 ISO 14971 FDA

Lifecycle documentation, design controls, risk management, validation, and regulatory readiness for software-based medical products.

Software Validation

CSA CSV IQ/OQ/PQ

Risk-based validation and verification for regulated software, cloud platforms, eQMS, LIMS, and healthcare interfaces.

Risk Management

ISO 14971 FMEA CAPA

Risk files, hazard analysis, control implementation, remediation, and effectiveness verification.

Audit Recovery

DHF 483 Remediation

Gap assessment, evidence rebuild, design-history remediation, and response support when findings already exist.

Interoperability Governance

HL7 FHIR EHR/LIMS

Quality and data-integrity controls across healthcare system boundaries, with interface validation built into the engagement.

Digital Health & SaMD

IEC 62304 · ISO 14971 · FDA · HIPAA · IEC 82304-1 · HL7/FHIR

Providers

CMS · JCI · ISO 9001 · interoperability controls

Clinical Laboratories

CLIA · CAP · ISO 15189 · validated laboratory interfaces

Payers

Healthcare data governance and compliance requirements applicable to payer platforms.

QMS IMPLEMENTATION

A structured path from discovery to sustained compliance.

Six stages. Each one takes a defined input, performs defined work, and produces an outcome that can be reviewed before the next stage begins.

Discover

INPUT

Current processes, records, systems, product roadmap, and audit history.

ACTIVITY

Assess the current state and identify quality and regulatory gaps.

OUTCOME

A prioritized view of gaps, risks, and requirements.

Design

INPUT

Gap register, product context, organizational scale, and regulatory pathway.

ACTIVITY

Design QMS processes, SOPs, controls, traceability, and governance.

OUTCOME

An approved quality and compliance architecture.

Build

INPUT

Approved QMS design and platform or workflow requirements.

ACTIVITY

Implement processes, configure eQMS workflows, integrate systems, and train teams.

OUTCOME

Controlled processes in operation with records being generated.

Validate

INPUT

Implemented processes and systems.

ACTIVITY

Execute risk-based validation, verification, protocols, and traceability checks.

OUTCOME

Documented evidence that supports intended use and compliance.

Submit

INPUT

Controlled evidence and applicable regulatory pathway.

ACTIVITY

Prepare submission or inspection materials and support readiness activities.

OUTCOME

Evidence organized for regulatory review or inspection.

Sustain

INPUT

Operating QMS, field data, complaints, and changing standards.

ACTIVITY

Run audits, CAPA, surveillance, change control, and standards monitoring.

OUTCOME

Compliance maintained as an operating state.

USE CASES

Where QMS & regulatory expertise creates practical value.

Engagements can start with a new product, an existing quality system, a regulatory milestone, or a remediation need.

Use case 01

Digital Health Platforms

Build a right-sized quality foundation that supports product delivery, evidence generation, and health-system procurement requirements.

Use case 02

SaMD Companies

Establish lifecycle records, risk controls, validation, and a defensible regulatory pathway as software moves toward clinical use.

Use case 03

Healthcare Providers

Strengthen quality governance and data integrity across clinical workflows, reporting, and connected healthcare systems.

Use case 04

Clinical Laboratories

Validate LIS, instrument, and interface workflows so result integrity and supporting evidence are demonstrable ahead of inspection.

Use case 05

Payers

Support quality and data-governance processes for platforms handling regulated healthcare information and operational workflows.

We deliver compliant, scalable, and audit-ready healthcare systems.

CASE STUDIES

Case studies

Real-world results from standards-based healthcare compliance across digital health, SaMD, medical device, and clinical laboratory workflows.

Lifecycle documentation rebuilt ahead of a 510(k) submission

IEC 62304 ISO 14971
Challenge

A clinical decision support module had been developed without IEC 62304 lifecycle records. Requirements, test evidence and risk analysis existed but were unlinked and could not support a submission.

Solution

Retrospective requirements reconstruction, a full ISO 14971 risk management file, and a traceability matrix connecting user needs to verification evidence and risk controls.

Impact

The submission proceeded on the original timeline, and the traceability structure became the operating standard for subsequent releases.

Design control and CAPA remediation following a 483 observation

ISO 13485 21 CFR 820
Challenge

Inspection findings cited inadequate design controls and unverified CAPA effectiveness across two product lines, against a fixed response deadline

Solution

Gap assessment, design history file remediation, and a rebuilt CAPA process with root cause methodology and mandatory effectiveness verification before closure.

Impact

A documented response was delivered within the response window, with the underlying process causes closed rather than the individual records patched.

LIS and instrument interface validation ahead of CAP inspection

CLIA CAP ISO 15189
Challenge

Instrument and LIS interfaces had been implemented over several years without formal validation, leaving result integrity undemonstrated ahead of inspection.

Solution

Risk-ranked interface inventory, IQ/OQ/PQ protocol development and execution, and HL7 message-level verification with traceable evidence.

Impact

Result integrity became demonstrable on request, and the protocol set now serves as the template for new instrument onboarding.

Why DASH

Compliance engineered into the way healthcare products are built.

DASH Technologies was founded in 2010 and is ISO 9001 and ISO 27001 certified, with MBE certifications through NMSDC and the State of Ohio.

01

Compliance embedded into SDLC

Design controls, traceability, and validation evidence are produced as part of the engineering workflow.

02

Faster regulatory readiness

Regulatory requirements and evidence expectations are addressed early, reducing avoidable downstream rework.

03

Reduced audit risk

Controlled documentation and connected evidence make inspection preparation more predictable.

04

Risk-based validation

CSA and validation effort are proportionate to actual risk, with deeper evidence where it matters most.

05

Digital compliance infrastructure

Quality workflows can connect with the clinical and engineering systems that generate the underlying data.

06

End-to-end ownership

Strategy, QMS, validation, remediation, and digital quality operations can be addressed as one connected program.

Compliance assessment

Ready to modernize your quality & regulatory operations?

Whether you’re preparing FDA submissions, implementing enterprise QMS, validating regulated software, or modernizing digital quality operations, our experts help you build compliant, scalable, and audit-ready healthcare systems.

  • 30-minute assessment call
  • No-obligation gap summary
  • Findings ranked by regulatory risk

    Frequently Asked Questions

    QMS and Regulatory Affairs services cover the design, implementation, validation and ongoing operation of the quality system and regulatory program a healthcare product requires. In practice that means process architecture and SOPs, design controls, risk management, software validation, submission support and post-market surveillance — delivered as an engineering discipline rather than a documentation exercise.

    Because in healthcare the product claim and the evidence behind it are inseparable. A QMS is what allows an organization to demonstrate — to a regulator, an auditor or a health-system buyer — that its product was built safely and consistently and can be maintained that way. Without one, clearance, procurement and market access all stall.

    FDA QMSR and 21 CFR Parts 820 and 11, ISO 13485, ISO 9001, IEC 62304, ISO 14971, EU MDR and IVDR, GAMP 5, HIPAA and HITECH, HL7 and FHIR, CLIA, CAP and ISO 15189, alongside SOC 2 and ISO 27001 for information security.

    QMS implementation establishes the processes that govern how work is done — SOPs, design controls, change control, CAPA. Software validation is one activity performed within those processes: producing documented evidence that a specific system performs as intended for its use. You can validate software without a QMS, but the evidence won’t be defensible; and a QMS without validation has no proof behind its claims.

    We start with a gap assessment against the applicable standards, then close findings in risk order — usually traceability and design control records first, since that is where inspections concentrate. Preparation includes mock audits with your own staff, so the people answering questions have done it once before the inspector arrives.

    Yes, and it should. Quality data is generated inside clinical and laboratory systems, so an eQMS that doesn’t connect to them creates duplicate entry and version drift. We integrate quality workflows with EHR, LIS and LIMS platforms using HL7 and FHIR interfaces, and validate those interfaces as part of the engagement.

    It depends on scope and starting state. A focused implementation for an early-stage SaMD product is commonly a matter of months; a full enterprise QMS across multiple product lines, or a remediation program under a response deadline, runs longer. We scope from the gap assessment rather than from a standard timeline, and sequence work so the highest-risk gaps close first.

    Yes. SaMD is a core focus, including AI and machine-learning-enabled products where lifecycle and change management need additional structure — Predetermined Change Control Plans, Good Machine Learning Practice principles, and the data governance that supports both.